Skip to ContentSkip to Navigation
About us Latest news News News articles

Major European research project on ADHD to get under way

12 April 2016

A major European research project on ADHD will soon be starting with the aim of investigating the causes and consequences of ADHD, and so contributing to prevention and better treatment of the disorder. The UMCG is coordinating an important part of the study. The EU recently awarded the grant that has allowed this research, involving 17 research institutes in 8 European countries, to go ahead. The data for the research conducted in Groningen will be provided by LifeLines.

More than 21 million people in Europe have ADHD. UMCG researcher Catharina Hartman is the project leader of the epidemiological part of the European study on ADHD. ‘The goal of our share in this large-scale European research project is to get a systematic picture of ADHD, from childhood to old age. We’re going to be looking at patterns of problems within families and the genetic background, across various countries.’ Hartman will do this using LifeLines, which will play an important role in the study – a special questionnaire will be filled in by children, adults and older adults participating in LifeLines. The LifeLines data will be compared and combined with data from other countries.

ADHD (attention deficit hyperactivity disorder) starts in childhood and often persists into adulthood, but little is known about it. It is not a stand-alone disorder, but often appears alongside other psychiatric problems. Over the course of a lifetime, individuals with ADHD may develop anxiety, depression, substance abuse and overweight. However, this is far from always being the case, making it very important to investigate why these other problems do or do not develop. Catharina Hartman: ‘Research on ADHD focuses almost exclusively on children up to 12 years old, as if the problems suddenly disappear after that age. This project is unique in that it will allow us to look at how ADHD develops over a whole lifetime. Hopefully, this will allow us to discover more about how additional problems developing alongside ADHD can be avoided and treated.’

Last modified:12 March 2020 9.41 p.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.